Sanofi and Orano Collaborate to Advance Next-Generation Radioligand Therapies
Sanofi and Orano Partner to Develop Next-Generation Radioligand Therapies Paris, October 17, 2024 – Sanofi and Orano Med, a subsidiary of the Orano Group and a leader in targeted alpha…
AstraZeneca Pushes Forward Infectious Disease Protection Science at IDWeek 2024
AstraZeneca Showcases Key Advances in Respiratory Infection Protection at IDWeek 2024 AstraZeneca is set to present significant new findings on the protection against serious respiratory infections caused by respiratory syncytial…
Etcembly and University of Surrey Launch Study on Next-Gen Cancer Treatments from Survivors
Etcembly and University of Surrey Launch Study to Transform Cancer Treatment British techbio innovator Etcembly is collaborating with researchers from the University of Surrey to launch a groundbreaking study aimed…
Merck’s CAPVAXIVE™ Vaccine Shows Positive Immune Response in Adults at Risk for Pneumococcal Disease
STRIDE-8 Study Results Highlight CAPVAXIVE’s Efficacy in Pneumococcal Disease Prevention CAPVAXIVE Demonstrates Strong Immune Response and Coverage Against Major Serotypes RAHWAY, N.J. — Merck (NYSE: MRK), known as MSD outside…
ViiV Healthcare Reports Over 99% Effectiveness for Apretude in Real-World Studies at IDWeek 2024
ViiV Healthcare Presents Real-World Evidence for Apretude (Cabotegravir Long-Acting) at IDWeek 2024 GSK plc (LSE/NYSE: GSK) has announced that ViiV Healthcare, a global leader in HIV treatment and prevention, has…
FDA Grants Priority Review for Gepotidacin to Treat Uncomplicated UTIs in Women and Adolescents
GSK’s Gepotidacin Accepted for FDA Priority Review to Treat Uncomplicated UTIs GSK plc (LSE/NYSE: GSK) has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug…
Bayer to Showcase New Research on Menopause Symptoms at IMS 2024
Bayer to Present Latest Research on Menopausal Sleep Disturbances at IMS 2024 Bayer is set to showcase its latest research on menopause symptoms, particularly sleep disturbances, at the 19th World…
Woman’s Brain Foundation and Medscape Education Launch Centre on Sex, Gender, and the Brain
The Women’s Brain Foundation and Medscape Education Launch Learning Center on Sex and Gender in Brain Health The Women’s Brain Foundation (WBF), a leader in integrating sex- and gender-based research…
Sensorion to Present GJB2-GT at European Society of Gene and Cell Therapy Congress
Sensorion to Present GJB2-GT Research at ESGCT Congress 2024 Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of innovative therapies for hearing loss, has announced…
GenSight Biologics Unveils LUMEVOQ® Scientific Updates at AAO 2024
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 GenSight Biologics (Euronext: SIGHT), a biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders,…
Verastem Oncology Highlights RAMP 201 Data for Avutometinib and Defactinib in Ovarian Cancer at IGCS 2024
Verastem Oncology Reports Promising RAMP 201 Data for Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer Verastem Oncology has announced encouraging results from its Phase 2 RAMP 201 trial, showcasing…
Horizon Surgical Systems Secures $30 Million in Series A Funding
ExSight Ventures Leads $30 Million Financing Round to Propel Development of the Polaris System for Eye Surgery Horizon Surgical Systems, a pioneering company specializing in micro-robotics for eye surgery, has…